|
JPH11322582A
|
|
Nasal mucosal sticking and retention type carrier for pernasal absorption
|
|
JPH10130171A
|
|
Pharmaceutical composition for oral administration
|
|
JPH09255586A
|
|
Biologically active peptide composition for nasal absorption
|
|
JPH09315953A
|
|
Physioligically active peptide composition for nasal absorption
|
|
JPH08277226A
|
|
Physiologically active peptide composition for pernasal absorption
|
|
JPH0827031A
|
|
Composition for nasal absorption
|
|
JPH08176011A
|
|
Therapeutic agent for aseptic epiphysical necrotic syndrome
|
|
JPH07165613A
|
|
Carrier for nasal absorption medicine and physiologically active peptide composition
|
|
JPH07285861A
|
|
External preparation
|
|
JPH07118170A
|
|
Carrier for nasal absorption agent, physiologically active peptide composition and their production
|
|
JPH07118166A
|
|
Insulin composition
|
|
JPH07118164A
|
|
Carrier for nasal absorption agent and physiologically active peptide composition
|
|
JPH0782147A
|
|
Indomethacin farnesyl-containing external preparation
|
